Tirzepatide Lyophilized High Purity 99% Peptide Powder TR 10mg 15mg 20mg 30mg per vial yeshuga yeropa/shuga

Tirzepatide inyowani glucose-inotsamira insulinotropic polypeptide/glucagon-yakafanana peptide 1 (GLP-1) receptor agonist yakabvumidzwa muUnited States seanopindirana nekudya uye maekisesaizi kuvandudza glycemic control muvanhu vakuru vane Type 2 chirwere cheshuga uye pasi pekuferefetwa kuti ishandiswe mukuremerwa uremu, hombe yakaipa yemoyo zviitiko uye manejimendi yemoyo kutadza uye kuchengetedzwa kwemamwe mamiriro, isiri-cirrhotic isiri-doro steatohepatitis. Iyo Phase 3 SURPASS 1-5 chirongwa chekiriniki chekuyedza chirongwa chakagadzirirwa kuongorora kushanda uye kuchengetedzeka kwekamwe-vhiki nevhiki subcutaneously jekiseni tirzepatide (5, 10 uye 15 mg), se monotherapy kana musanganiswa kurapa, muhuwandu hwakawanda hwevanhu vane Type 2 chirwere cheshuga. Kushandiswa kwetirzepatide muzvidzidzo zvekiriniki kwaibatanidza nekudzikira kwakaratidza kuderera kweglycated hemoglobin (-1.87 kusvika -2.59%, -20 kusvika -28 mmol/mol) uye uremu hwemuviri (-6.2 kusvika -12.9 kg), pamwe nekudzikira kwezvimiro zvinowanzobatanidzwa nekuwedzera kwehutano hwemoyo hwakadai seBP, viscerides uye kutenderera kweropa. Tirzepatide yakatenderwa zvakanaka, ine njodzi yakaderera yehypoglycaemia kana ikashandiswa pasina insulin kana insulin secretagogues uye yakaratidza yakajairika yakafanana yekuchengetedza nhoroondo kune yeGLP-1 receptor agonist kirasi. Saizvozvo, humbowo kubva kumakiriniki ekuyedzwa hunoratidza kuti tirzepatide inopa mukana mutsva wekudzikisa kunoshanda kweglycated hemoglobin uye uremu hwemuviri kune vanhu vakuru vane Type 2 chirwere cheshuga.